News & Updates

Paragon Genomics NGS Panel Captures New SARS-CoV-2 Mutations

01/24/2021

Excerpt from the Press Release: Paragon Genomics, Inc., a leader in amplicon-based target enrichment solutions for next-generation sequencing (NGS) and precision medicine, today announced a solution for capturing the new mutations of the SARS-CoV-2 variants that have been sweeping across the United Kingdom and South Africa, and already finding its way in various countries worldwide.…

Read More

Webinar – Safer Technologies Program: Final Guidance

01/23/2021

Summary: On Monday, February 1, 2021, the FDA will host a webinar on the Safer Technologies Program for industry and other stakeholders interested in learning more about the Program and final guidance. Background: The U.S. Food and Drug Administration (FDA) issued a final guidance outlining the Safer Technologies Program for Medical Devices. This program is a…

Read More

Menon Announces Advancement of Trials on Rapid COVID-19 Test at the University of California San Diego

01/22/2021

Excerpt from the Press Release: SAN DIEGO, Jan. 19, 2021 /PRNewswire/ — Menon Biosensors, Inc. (“Menon” or the “Company”), a distributive technology portfolio company, announced today that trials will advance on its proprietary Molecular Mirror™ platform technology in collaboration with the University of California San Diego School of Medicine (“UC San Diego”) hoping to prove accuracy…

Read More

Penn Physicist, Physician Team Awarded $2 Million NIH Grant to Develop Portable COVID-19 Detector for Use in Public Spaces

01/21/2021

Excerpt from the Article: PHILADELPHIA — A team led by physicists at the University of Pennsylvania and physicians at the University’s Perelman School of Medicine has been awarded a two-year, $2 million grant by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences for the development of a handheld device that can…

Read More

Cyxone reports first Covid-19 patient screened in Phase 2 clinical trial of Rabeximod

01/20/2021

Excerpt from the Press Release: STOCKHOLM, Jan. 15, 2021 /PRNewswire/ — Cyxone (publ.) announced today that the first patient has been screened in the Phase 2 clinical trial of Rabeximod in Covid-19. The trial will evaluate the efficacy and safety of oral treatment with Rabeximod to prevent disease progression in hospitalized Covid-19 patients and shorten…

Read More

Non-Invasive Imaging Can Measure Cell Dysfunction in Patients with ALS

01/19/2021

Excerpt from the Article: A new non-invasive magnetic resonance spectroscopy technique could help providers measure how well treatments are working for patients with amyotrophic lateral sclerosis (ALS), new research has found. Specifically known as 31-phosphorus magnetic resonance spectroscopy can measure how well the mitochondria is working in patients who have this motor neuron disease (MND),…

Read More

Kaleido Biosciences Announces Positive Interim Results of Controlled Study of KB109 in Patients with Mild-to-Moderate COVID-19

01/19/2021

Excerpt from the Press Release: LEXINGTON, Mass., Jan. 14, 2021 (GLOBE NEWSWIRE) — Kaleido Biosciences, Inc. (Nasdaq: KLDO), today announced positive interim results from the K031 non-IND controlled clinical study evaluating outpatients with mild to moderate COVID-19 disease. Patients in this non-IND clinical study were randomized within 48 hours of testing positive for COVID-19 to…

Read More

17 Black innovators who made medtech better

01/18/2021

Excerpt from the Article: From cardiology to endoscopy to blood transfusion, African Americans have played an important role as innovators in the history of medicine and medtech. To help mark African American History Month, here’s a look at some of their greatest achievements. Here are 17 African American innovators who have made discoveries and invented…

Read More

Chest Imaging Shows Little Long-Term Lung Scarring from COVID-19

01/18/2021

Excerpt from the Article: How well a patient’s lungs recover post-COVID-19 infection is not necessarily linked with the severity of his or her disease course, but imaging shows that most patients do not experience long-term fibrosis. To date, little research has focused on lung health post-recovery, and not much is known about whether the lingering…

Read More

Innovation Pharmaceuticals’ Brilacidin for the Treatment of COVID-19 Receives FDA Fast Track Designation

01/18/2021

Excerpt from the Press Release: Phase 2 clinical trial of Brilacidin for COVID-19 anticipated to commence this month Email Print Friendly ShareJanuary 14, 2021 07:30 ET | Source: Innovation Pharmaceuticals Inc. WAKEFIELD, Mass., Jan. 14, 2021 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to announce that the…

Read More

Request Your Demo Today!

From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?

Archives